Industry: Medical Devices & Consumables
Published Date: 2025-07-31
Pages: 121 Pages
Report ld: 4809528
Request Sample
Customized Report
Immunoadsorption Columns Market Size(US$)

CAGR 2025-2031
7.6%
Market Size,2031
USD 53.7
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Immunoadsorption Columns market is projected to grow from US$ 32.4 million in 2024 to US$ 53.7 million by 2031, at a CAGR of 7.6% (2025-2031), driven by critical product segments and diverse end‑use applications.
Immunoadsorption columns have been widely employed for the purification of specific antibodies and antigens. In immunoadsorption columns, plasma is removed by apheresis and passed on through an adsorption medium to remove harmful antibodies, following which it is re-infused into the patient.
Immunoadsorption columns are increasingly being recognised as a promising and low-risk therapy option in a variety of cardiac, haematological, neurological and various other disorders. Immunoadsorption columns are also being increasingly recognised as a useful therapeutic option for various chronic and acute disorders such as multiple sclerosis, Guillain-Barre, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy and autoimmune encephalitis. Using immunoadsorption columns, plasma components are separated by adsorber systems that are designed to selectively bind immunoglobulins. The preservation of plasma proteins, such as coagulation factors, albumin and lower shift of blood volumes, during a procedure is one of the advantages of immunoadsorption columns over other conventional techniques such as plasma exchange.
Various different adsorbers, such as tryptophan, protein A or polyclonal sheep antibodies, can be used alone with immunoadsorption columns. Immunoadsorption columns with protein A or sheep antibodies enable more selective removal of immunoglobulins as well as regenerating mechanisms. Most of the modern immunoadsorption columns contain 2 columns that undergo alternating loading and regeneration cycles, which assists in saving time for even larger blood volumes to be processed.
Global immunoadsorption column includes Asahi Kasei, Fresenius Medical Care Adsorber, etc. Global top 3 companies hold a share about 80%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific with the share about 30% respectively. In terms of product, single-use is the largest segment, with a share over 70%. And in terms of application, the largest application is hospital, with a share about 80%.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Immunoadsorption Columns market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Immunoadsorption Columns study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Immunoadsorption Columns: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Immunoadsorption Columns Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Single Use Immunoadsorption Columns
1.2.3 Reuse Immunoadsorption Columns
1.3 Market Segmentation by Application
1.3.1 Global Immunoadsorption Columns Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Academic & Research Centres
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Immunoadsorption Columns Revenue Estimates and Forecasts 2020-2031
2.2 Global Immunoadsorption Columns Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Immunoadsorption Columns Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Immunoadsorption Columns Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Single Use Immunoadsorption Columns Market Size by Players
3.3.2 Reuse Immunoadsorption Columns Market Size by Players
3.4 Global Immunoadsorption Columns Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Immunoadsorption Columns Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Immunoadsorption Columns Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Immunoadsorption Columns Market Size by Type (2020-2031)
6.4 North America Immunoadsorption Columns Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Immunoadsorption Columns Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Immunoadsorption Columns Market Size by Type (2020-2031)
7.4 Europe Immunoadsorption Columns Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Immunoadsorption Columns Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Immunoadsorption Columns Market Size by Type (2020-2031)
8.4 Asia-Pacific Immunoadsorption Columns Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Immunoadsorption Columns Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Immunoadsorption Columns Market Size by Type (2020-2031)
9.4 Central and South America Immunoadsorption Columns Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Immunoadsorption Columns Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Immunoadsorption Columns Market Size by Type (2020-2031)
10.4 Middle East and Africa Immunoadsorption Columns Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Immunoadsorption Columns Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Fresenius Medical Care Adsorber Tec
11.1.1 Fresenius Medical Care Adsorber Tec Corporation Information
11.1.2 Fresenius Medical Care Adsorber Tec Business Overview
11.1.3 Fresenius Medical Care Adsorber Tec Immunoadsorption Columns Product Features and Attributes
11.1.4 Fresenius Medical Care Adsorber Tec Immunoadsorption Columns Revenue and Gross Margin (2020-2025)
11.1.5 Fresenius Medical Care Adsorber Tec Immunoadsorption Columns Revenue by Product in 2024
11.1.6 Fresenius Medical Care Adsorber Tec Immunoadsorption Columns Revenue by Application in 2024
11.1.7 Fresenius Medical Care Adsorber Tec Immunoadsorption Columns Revenue by Geographic Area in 2024
11.1.8 Fresenius Medical Care Adsorber Tec Immunoadsorption Columns SWOT Analysis
11.1.9 Fresenius Medical Care Adsorber Tec Recent Developments
11.2 Asahi Kasei
11.2.1 Asahi Kasei Corporation Information
11.2.2 Asahi Kasei Business Overview
11.2.3 Asahi Kasei Immunoadsorption Columns Product Features and Attributes
11.2.4 Asahi Kasei Immunoadsorption Columns Revenue and Gross Margin (2020-2025)
11.2.5 Asahi Kasei Immunoadsorption Columns Revenue by Product in 2024
11.2.6 Asahi Kasei Immunoadsorption Columns Revenue by Application in 2024
11.2.7 Asahi Kasei Immunoadsorption Columns Revenue by Geographic Area in 2024
11.2.8 Asahi Kasei Immunoadsorption Columns SWOT Analysis
11.2.9 Asahi Kasei Recent Developments
11.3 Miltenyi Biotec
11.3.1 Miltenyi Biotec Corporation Information
11.3.2 Miltenyi Biotec Business Overview
11.3.3 Miltenyi Biotec Immunoadsorption Columns Product Features and Attributes
11.3.4 Miltenyi Biotec Immunoadsorption Columns Revenue and Gross Margin (2020-2025)
11.3.5 Miltenyi Biotec Immunoadsorption Columns Revenue by Product in 2024
11.3.6 Miltenyi Biotec Immunoadsorption Columns Revenue by Application in 2024
11.3.7 Miltenyi Biotec Immunoadsorption Columns Revenue by Geographic Area in 2024
11.3.8 Miltenyi Biotec Immunoadsorption Columns SWOT Analysis
11.3.9 Miltenyi Biotec Recent Developments
11.4 POCARD Ltd
11.4.1 POCARD Ltd Corporation Information
11.4.2 POCARD Ltd Business Overview
11.4.3 POCARD Ltd Immunoadsorption Columns Product Features and Attributes
11.4.4 POCARD Ltd Immunoadsorption Columns Revenue and Gross Margin (2020-2025)
11.4.5 POCARD Ltd Immunoadsorption Columns Revenue by Product in 2024
11.4.6 POCARD Ltd Immunoadsorption Columns Revenue by Application in 2024
11.4.7 POCARD Ltd Immunoadsorption Columns Revenue by Geographic Area in 2024
11.4.8 POCARD Ltd Immunoadsorption Columns SWOT Analysis
11.4.9 POCARD Ltd Recent Developments
11.5 Jafron Biomedical
11.5.1 Jafron Biomedical Corporation Information
11.5.2 Jafron Biomedical Business Overview
11.5.3 Jafron Biomedical Immunoadsorption Columns Product Features and Attributes
11.5.4 Jafron Biomedical Immunoadsorption Columns Revenue and Gross Margin (2020-2025)
11.5.5 Jafron Biomedical Immunoadsorption Columns Revenue by Product in 2024
11.5.6 Jafron Biomedical Immunoadsorption Columns Revenue by Application in 2024
11.5.7 Jafron Biomedical Immunoadsorption Columns Revenue by Geographic Area in 2024
11.5.8 Jafron Biomedical Immunoadsorption Columns SWOT Analysis
11.5.9 Jafron Biomedical Recent Developments
11.6 Guangzhou Kangsheng Biotechnology
11.6.1 Guangzhou Kangsheng Biotechnology Corporation Information
11.6.2 Guangzhou Kangsheng Biotechnology Business Overview
11.6.3 Guangzhou Kangsheng Biotechnology Immunoadsorption Columns Product Features and Attributes
11.6.4 Guangzhou Kangsheng Biotechnology Immunoadsorption Columns Revenue and Gross Margin (2020-2025)
11.6.5 Guangzhou Kangsheng Biotechnology Recent Developments
12 Immunoadsorption ColumnsIndustry Chain Analysis
12.1 Immunoadsorption Columns Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Immunoadsorption Columns Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Immunoadsorption Columns Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Immunoadsorption Columns market is projected to grow from US$ 34.6 million in 2025 to US$ 57.37 million by 2032, at a CAGR of 7.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 124
USD 4900.00
(Single User License)
The global Immunoadsorption Columns market size was US$ 34.6 million in 2025 and is forecast to reach a readjusted size of US$ 57.37 million by 2032 with a CAGR of 7.6% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 76
USD 4250.00
(Single User License)
The global Immunoadsorption Columns market was valued at US$ 34.6 million in 2025 and is anticipated to reach US$ 57.37 million by 2032, at a CAGR of 7.6% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 105
USD 2900.00
(Single User License)
The global market for Immunoadsorption Columns was estimated to be worth US$ 34.6 million in 2025 and is projected to reach US$ 57.37 million, growing at a CAGR of 7.6% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 97
USD 3950.00
(Single User License)
The global Immunoadsorption Columns market size was US$ 32.4 million in 2024 and is forecast to a readjusted size of US$ 53.7 million by 2031 with a CAGR of 7.6% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 76
USD 4250.00
(Single User License)
The global market for Immunoadsorption Columns was estimated to be worth US$ 32.4 million in 2024 and is forecast to a readjusted size of US$ 53.7 million by 2031 with a CAGR of 7.6% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 98
USD 3950.00
(Single User License)
The global market for Immunoadsorption Columns was valued at US$ 32.4 million in the year 2024 and is projected to reach a revised size of US$ 53.7 million by 2031, growing at a CAGR of 7.6% during the forecast period.
Published Date: 2025-01-19
Pages: 73
USD 2900.00
(Single User License)
Immunoadsorption columns have been widely employed for the purification of specific antibodies and antigens. In immunoadsorption columns, plasma is removed by apheresis and passed on through an adsorption medium to remove harmful antibodies, following which it is re-infused into the patient.
Published Date: 2024-01-18
Pages: 92
USD 3950.00
(Single User License)
The global Immunoadsorption Columns market is projected to grow from US$ 34.6 million in 2025 to US$ 57.37 million by 2032, at a CAGR of 7.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 124
The global Immunoadsorption Columns market size was US$ 34.6 million in 2025 and is forecast to reach a readjusted size of US$ 57.37 million by 2032 with a CAGR of 7.6% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 76
The global Immunoadsorption Columns market was valued at US$ 34.6 million in 2025 and is anticipated to reach US$ 57.37 million by 2032, at a CAGR of 7.6% from 2026 to 2032.
Published: 2026-03-12
Pages: 105
The global market for Immunoadsorption Columns was estimated to be worth US$ 34.6 million in 2025 and is projected to reach US$ 57.37 million, growing at a CAGR of 7.6% from 2026 to 2032.
Published: 2026-03-12
Pages: 97
The global Immunoadsorption Columns market size was US$ 32.4 million in 2024 and is forecast to a readjusted size of US$ 53.7 million by 2031 with a CAGR of 7.6% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 76
The global market for Immunoadsorption Columns was estimated to be worth US$ 32.4 million in 2024 and is forecast to a readjusted size of US$ 53.7 million by 2031 with a CAGR of 7.6% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 98
The global market for Immunoadsorption Columns was valued at US$ 32.4 million in the year 2024 and is projected to reach a revised size of US$ 53.7 million by 2031, growing at a CAGR of 7.6% during the forecast period.
Published: 2025-01-19
Pages: 73
Immunoadsorption columns have been widely employed for the purification of specific antibodies and antigens. In immunoadsorption columns, plasma is removed by apheresis and passed on through an adsorption medium to remove harmful antibodies, following which it is re-infused into the patient.
Published: 2024-01-18
Pages: 92
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now